Antithrombin IIi during coagulation in vitro
Aiach, M.; Andreux, J.P.; Fiessinger, J.N.; Beuvin, J.; Leclerc, M.
Annales Pharmaceutiques Francaises 34(1-2): 43-50
1976
ISSN/ISBN: 0003-4509 PMID: 970875 Document Number: 97068
Document emailed within 1 workday
Related Documents
Fujimaki, M.; Nagasawa, H. 1974: Coagulation inhibitory factor: antithrombin--with special reference to antithrombin 3 Nihon Rinsho. Japanese Journal of Clinical Medicine 32(5): 942-947Shinyama, H.; Akira, T.; Uchida, T.; Hirahara, K.; Watanabe, M.; Kagitani, Y. 1996: Antithrombin III prevents renal dysfunction and hypertension induced by enhanced intravascular coagulation in pregnant rats: pharmacological confirmation of the benefits of treatment with antithrombin III in preeclampsia Journal of Cardiovascular Pharmacology 27(5): 702-711
Kase, F.; Pospísil, J. 1983: The physiological inhibitors of blood coagulation. 1. Antithrombin IIi (AT III) Folia Haematologica 110(3): 337-349
Król-Grela, H.; Piastucka, B.; Skotnicki, A.B. 1988: The role of antithrombin III in disorders of blood coagulation Przeglad Lekarski 45(6): 516-520
Bärtsch, P.; Haeberli, A.; Straub, P.W. 1990: Blood coagulation after long distance running: antithrombin III prevents fibrin formation Thrombosis and Haemostasis 63(3): 430-434
Saxena, V.; Mishra, D.K.; Subramanya, H.; Satyanarayana, S.; Sharma, A. 2004: Antithrombin IIi assay using thrombin in disseminated intravascular coagulation (DIC), other thromboembolic disorders and hepatic diseases Indian Journal of Pathology and Microbiology 47(2): 210-212
Dolesobel, W. 1972: Use of new methods for studies of blood coagulation. II. Clot-sedimentation-technic for the determination of antithrombin i effect of fibrin Wiener Medizinische Wochenschrift 122(41): 585-590
Leroy-Matheron, C.; Gouault-Heilmann, M. 1994: Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements Thrombosis Research 74(4): 399-407
Weiler, J.M.; Linhardt, R.J. 1991: Antithrombin III regulates complement activity in vitro Journal of Immunology 146(11): 3889-3894
Stürner, K.H.; Holzhüter, H.; Ochs, H.G.; Angelkort, B.; Muchietti, F.; Wenzel, E. 1973: Reliability of reptilase and thrombin coagulase coagulation times for measurement of antithrombin VI activity with reference to immunoelectrophoretic characteristics of various fibrinogen and fibrin fission products Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1328-1330
Wencel, K. 1992: Natural factors inhibiting blood coagulation (antithrombin III, protein C and protein S) Polski Tygodnik Lekarski 47(16-17): 377-380
Nakagawa, M. 1993: Heparin, low molecular weight heparin, heparinoid, and antithrombin IIi therapy of disseminated intravascular coagulation Nihon Rinsho. Japanese Journal of Clinical Medicine 51(1): 87-92
Gouault-Heilmann, M.; Contant, G.; Pochmalicki, G.; Jan, F. 1984: Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin IIi Presse Medicale 13(22): 1393-1394
Palareti, G.; Legnani, C.; Ludovici, S.; Maccaferri, M. 1990: Preliminary study for the evaluation of the feasibility of a multicenter clinical trial for the evaluation of the therapeutic efficacy of an antithrombin IIi concentration (Immuno) in the intravascular coagulation syndrome Haematologica 75(Suppl 2): 21-32
Kamikubo, Y.; Hamuro, T.; Matsuda, J.; Shinya, N.; Miyamoto, S.; Funatsu, A.; Kato, H. 1996: Antithrombotic effect of human recombinant tissue factor pathway inhibitor on endotoxin-induced intravascular coagulation in rats: concerted effect with antithrombin Thrombosis and Haemostasis 76(4): 621-626
Psuja, P. 1988: Effect of antithrombin IIi on the binding of heparin and its low molecular weight fraction CY 216 with endothelium in vitro Acta Haematologica Polonica 19(3-4): 143-149
Jeong, H.; Kim, M.; Lee, J.; Hahn, S.H.; Park, S.; Yoo, O.J. 1997: A 5-nucleotide insertion in the antithrombin gene causing a quantitative antithrombin deficiency Thrombosis and Haemostasis 77(1): 212-213
Gerhards, H. 1987: Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency Tierarztliche Praxis 15(1): 47-55
Lewandowski, J.J.; Galar, M.; Mazgajska-Barczyk, K.; Panek, M.; Kłoczko, J. 2002: Antithrombin III, protein C and thrombin/antithrombin IIi complexes (TAT) in patients suffering from chronic cholecystolithiasis treated by classical and laparoscopic cholecystectomy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(74): 119-122
Ishida, Y.; Yano, K.; Ito, T.; Shigematus, H.; Sasaki, K.; Kondo, S.; Kuriya, S. 2001: Purification of proplatelet formation (PPF) stimulating factor: thrombin/antithrombin III complex stimulates PPF of megakaryocytes in vitro and platelet production in vivo Thrombosis and Haemostasis 85(2): 349-355